Septerna (SEPN) Capital Expenditures (2023 - 2026)

Septerna's quarterly Capital Expenditures came in at $832000.0 in Q1 2026, up 117.8% year-on-year from $382000.0 in Q1 2025, and up 1180.0% quarter-over-quarter from $65000.0 in Q4 2025.

Septerna has reported Capital Expenditures for 4 years, with the latest figure at $832000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures rose 117.8% year-over-year to $832000.0; the trailing twelve-month figure through Mar 2026 stood at $968000.0 (down 43.75% YoY), and the FY2025 full-year result was $518000.0, down 75.37% from the prior year.
  • Capital Expenditures for Q1 2026 stood at $832000.0, up from $65000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $1.2 million in Q4 2023, with the low at $13000.0 in Q3 2025.
  • Average Capital Expenditures over 4 years is $469200.0, with a median of $480000.0 recorded in 2024.
  • Year-over-year, Capital Expenditures slumped 97.75% in 2025 and surged 117.8% in 2026.
  • Tracing SEPN's Capital Expenditures over 4 years: stood at $1.2 million in 2023, then slumped by 50.61% to $612000.0 in 2024, then slumped by 89.38% to $65000.0 in 2025, then jumped by 1180.0% to $832000.0 in 2026.
  • The last three Capital Expenditures figures came in at $832000.0 (Q1 2026), $65000.0 (Q4 2025), and $13000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 133.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 230.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 21.83 Mn
10 Septerna 1.34 Bn 1.34 Bn - 832,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 832,000.00
Mar 31, 2026 832,000.00
Dec 31, 2025 65,000.00
Dec 31, 2025 65,000.00
Sep 30, 2025 13,000.00
Sep 30, 2025 13,000.00
Jun 30, 2025 58,000.00
Jun 30, 2025 58,000.00
Mar 31, 2025 382,000.00
Mar 31, 2025 382,000.00
Dec 31, 2024 612,000.00
Dec 31, 2024 612,000.00
Sep 30, 2024 578,000.00
Sep 30, 2024 578,000.00
Jun 30, 2024 149,000.00
Jun 30, 2024 149,000.00
Mar 31, 2024 764,000.00
Mar 31, 2024 764,000.00
Dec 31, 2023 1.24 Mn
Dec 31, 2023 1.24 Mn